A Phase I/IIa, Open Label, Single Site Light Dose Escalation Trial of Single Dose Verteporfin Photodynamic Therapy (PDT) in Primary Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 09 Apr 2018
At a glance
- Drugs Verteporfin (Primary)
- Indications Early breast cancer
- Focus Adverse reactions
- 04 Apr 2018 Status changed from recruiting to completed.
- 16 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 16 Mar 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.